Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.

Autor: Gui G; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Ravindra N; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Hegde PS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Andrew G; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Mukherjee D; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Wong Z; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Auletta JJ; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA.; The Ohio State University College of Medicine, Columbus, OH, USA., El Chaer F; University of Virginia, Charlottesville, VA, USA., Chen EC; Dana-Farber Cancer Institute, Boston, MA, USA., Chen YB; Massachusetts General Hospital, Boston, MA, USA., Corner A; Bio-Rad Laboratories, Pleasanton, CA, USA., Devine SM; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA., Iyer SG; Columbia University Irving Medical Center, New York, NY, USA., Jimenez Jimenez AM; Sylvester Comprehensive Cancer Center, Miami, FL, USA., De Lima MJG; The Ohio State University College of Medicine, Columbus, OH, USA., Litzow MR; Mayo Clinic, Rochester, MN, USA., Kebriaei P; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Saber W; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Spellman SR; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA., Zeger SL; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Page KM; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. laura.dillon2@nih.gov., Hourigan CS; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA. hourigan@vt.edu.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.

Autor: Shaffer BC; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Gooptu M; Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA., DeFor TE; CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN., Maiers M; CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN., Bolaños-Meade J; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Abboud R; Washington University School of Medicine, St Louis, MO., Briggs AD; Cancer Transplant Institute at HonorHealth, Scottsdale, AZ., Khimani F; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Modi D; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI., Newcomb R; Massachusetts General Hospital, Boston, MA., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Bupp C; CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN., Spellman SR; CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN., Stefanski HE; CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN., Shaw BE; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Auletta JJ; CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN.; Hematology/Oncology/BMT and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH., Devine SM; CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN., Jimenez Jimenez AM; Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL., Al Malki MM; City of Hope National Medical Center, Duarte, CA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct; Vol. 42 (28), pp. 3277-3286. Date of Electronic Publication: 2024 Jul 17.

Emergence of maribavir resistance after CMV treatment in hematopoietic stem cell transplant recipient.

Autor: Bini Viotti J; Jackson Health System, Miami Transplant Institute, Miami, FL, USA.; Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA., Dammann F; Jackson Health System, Miami Transplant Institute, Miami, FL, USA.; Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA., Jimenez Jimenez AM; Division of Transplantation and Cellular Therapy, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA., Anderson AD; Department of Pharmacy Services, University of Miami Miller School of Medicine, Miami, FL, USA., Morris MI; Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA., Camargo JF; Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA., Raja M; Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. mxr1829@med.miami.edu.

Publikováno v: Annals of hematology [Ann Hematol] 2023 Aug; Vol. 102 (8), pp. 2283-2284. Date of Electronic Publication: 2023 May 15.

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.

Autor: Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Gui G; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Page KM; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.; Medical College of Wisconsin, Milwaukee., Ravindra N; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Wong ZC; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Andrew G; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Mukherjee D; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Zeger SL; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., El Chaer F; University of Virginia, Charlottesville., Spellman S; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.; National Marrow Donor Program, Minneapolis, Minnesota., Howard A; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.; National Marrow Donor Program, Minneapolis, Minnesota., Chen K; National Marrow Donor Program, Minneapolis, Minnesota., Auletta J; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.; The Ohio State University College of Medicine, Columbus., Devine SM; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota., Jimenez Jimenez AM; Sylvester Comprehensive Cancer Center, Miami, Florida., De Lima MJG; The Ohio State University College of Medicine, Columbus., Litzow MR; Mayo Clinic, Rochester, Minnesota., Kebriaei P; University of Texas MD Anderson Cancer Center, Houston., Saber W; Medical College of Wisconsin, Milwaukee.; National Marrow Donor Program, Minneapolis, Minnesota., Weisdorf DJ; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.; University of Minnesota, Minneapolis., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Myeloid Malignancies Program, National Institutes of Health, Bethesda, Maryland.

Publikováno v: JAMA [JAMA] 2023 Mar 07; Vol. 329 (9), pp. 745-755.

Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.

Autor: Jimenez Jimenez AM; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA. amjimenez@med.miami.edu., De Lima M; Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA., Komanduri KV; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA., Wang TP; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA., Zhang MJ; (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA., Chen K; (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Abdel-Azim H; Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Abid MB; Divisions of Hematology/Oncology & Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia., Alkhateeb H; Mayo Clinic Rochester, Rochester, MN, USA., Assal A; Columbia University Irving Medical Center, Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, New York, NY, USA., Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Baron F; CHU and University of Liege, Liege, Belgium., Battiwalla M; Sarah Cannon Blood Cancer Network, Nashville, TN, USA., Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA., Bejanyan N; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA., Bhatt VR; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA., Byrne M; Vanderbilt University Medical Center, Nashville, TN, USA., Cahn JY; Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France., Cairo M; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA., Castillo P; UF Health Shands Children's Hospital, Gainesville, FL, USA., Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA., Perez MAD; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Elsawy M; Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada., Gale RP; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK., George B; Christian Medical College, Vellore, India., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Hogan WJ; Division of Hematology/BMT, Mayo Clinic, Rochester, MN, USA., Kanakry CG; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kansagra A; UT Southwestern Medical Center, Blood and Marrow Transplant Program, Dallas, TX, USA., Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Khera N; Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA., Krem MM; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA., Lazaryan A; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA., Maakaron J; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Martino R; Divison of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., McGuirk J; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Minneapolis, MN, USA., Michelis FV; Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada., Milone G; Azienda Ospedaliera Universitaria Policlinico-San Marco, Catania, Italy., Mishra A; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA., Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Mussetti A; Hematology Department, Institut Catalá d' Oncologia-Hospitalet, Barcelona, Spain.; IDIBELL-Institut Catalá d' Oncologia, l'Hospitalet de Llobregat, El Prat de Llobregat, Spain., Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA., Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA., Olsson RF; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden., Palmisiano N; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Patel S; Blood and Marrow Transplant Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Saad A; Division of Hematology, Ohio State University, Columbus, OH, USA., Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Solh M; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA., Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, the Netherlands., Wirk B; Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, PA, USA., Yared JA; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA., Litzow M; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA., Kebriaei P; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hourigan CS; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, MD, USA., Saber W; (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2022 May; Vol. 57 (5), pp. 852.